Memphasys Ltd (MEM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Memphasys Ltd (MEM) has a cash flow conversion efficiency ratio of -0.306x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.23 Million ≈ $-871.57K USD) by net assets (AU$4.02 Million ≈ $2.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Memphasys Ltd (MEM) balance sheet quality index to measure how much of total assets are equity-financed.
Memphasys Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Memphasys Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Memphasys Ltd to evaluate the quality of earnings relative to operating cash generation.
Memphasys Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Memphasys Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
South Star Mining Corp
V:STS
|
-0.278x |
|
Western Mines Group Ltd
AU:WMG
|
0.019x |
|
Bodycote PLC
LSE:BOY
|
0.096x |
|
Ateliers Mecaniques D’Indonesie Tbk PT
JK:AMIN
|
0.114x |
|
Orion Digital Corp.
NASDAQ:ORIO
|
0.051x |
|
Yong Tai Bhd
KLSE:7066
|
0.005x |
|
NexturnBioscience Co. Ltd
KQ:089140
|
0.019x |
|
Orion Digital Corp.
TO:ORIO
|
0.051x |
Annual Cash Flow Conversion Efficiency for Memphasys Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Memphasys Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Memphasys Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$5.37 Million ≈ $3.80 Million |
AU$-2.41 Million ≈ $-1.71 Million |
-0.449x | +5.01% |
| 2024-06-30 | AU$6.84 Million ≈ $4.84 Million |
AU$-3.23 Million ≈ $-2.29 Million |
-0.473x | -148.09% |
| 2023-06-30 | AU$7.38 Million ≈ $5.23 Million |
AU$-1.41 Million ≈ $-995.31K |
-0.190x | -567.12% |
| 2022-06-30 | AU$7.65 Million ≈ $5.41 Million |
AU$311.82K ≈ $220.63K |
0.041x | +685.09% |
| 2021-06-30 | AU$8.61 Million ≈ $6.09 Million |
AU$44.71K ≈ $31.63K |
0.005x | -57.84% |
| 2020-06-30 | AU$9.76 Million ≈ $6.90 Million |
AU$120.19K ≈ $85.05K |
0.012x | +110.57% |
| 2019-06-30 | AU$6.07 Million ≈ $4.30 Million |
AU$-707.47K ≈ $-500.58K |
-0.117x | +47.11% |
| 2018-06-30 | AU$3.35 Million ≈ $2.37 Million |
AU$-738.42K ≈ $-522.48K |
-0.220x | -107.21% |
| 2017-06-30 | AU$-402.24K ≈ $-284.61K |
AU$-1.23 Million ≈ $-869.31K |
3.054x | +455.22% |
| 2016-06-30 | AU$1.48 Million ≈ $1.05 Million |
AU$-1.27 Million ≈ $-899.02K |
-0.860x | +73.50% |
| 2015-06-30 | AU$746.59K ≈ $528.26K |
AU$-2.42 Million ≈ $-1.71 Million |
-3.244x | -442.08% |
| 2014-06-30 | AU$-992.85K ≈ $-702.50K |
AU$-941.64K ≈ $-666.27K |
0.948x | +771.03% |
| 2013-06-30 | AU$6.99 Million ≈ $4.95 Million |
AU$-987.97K ≈ $-699.05K |
-0.141x | +1.56% |
| 2012-06-30 | AU$4.56 Million ≈ $3.23 Million |
AU$-655.09K ≈ $-463.52K |
-0.144x | +40.80% |
| 2011-06-30 | AU$7.00 Million ≈ $4.95 Million |
AU$-1.70 Million ≈ $-1.20 Million |
-0.243x | -18.49% |
| 2010-06-30 | AU$12.84 Million ≈ $9.09 Million |
AU$-2.63 Million ≈ $-1.86 Million |
-0.205x | +79.64% |
| 2009-06-30 | AU$-398.47K ≈ $-281.94K |
AU$400.62K ≈ $283.46K |
-1.005x | +72.30% |
| 2008-06-30 | AU$1.10 Million ≈ $779.28K |
AU$-4.00 Million ≈ $-2.83 Million |
-3.630x | -- |
About Memphasys Ltd
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port… Read more